CompletedPhase 3NCT01599936
Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting Envenomation
Studying Scorpion envenomation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Principal Investigator
- Walter Garcia Ubbelohde, MDInstituto Bioclon
- Intervention
- Anascorp(biological)
- Enrollment
- 50 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2007
Study locations (3)
- San Carlos Indian Hospital, San Carlos, Arizona, United States
- Tucson Medical Center, Tucson, Arizona, United States
- University Medical Center, Tucson, Arizona, United States
Collaborators
University of Arizona · Universidad Nacional Autonoma de Mexico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01599936 on ClinicalTrials.gov